Back to EPRX
Aisling Capital Management LP → EPRX
Aisling Capital Management LP EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
3
Latest value
$3M
Q3 2026
Peak value
$3M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $2.4M |
| Q2 2026 | $2.1M |
| Q3 2026 | $3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3M | 325.0K | — | — |
| Q2 2026 | $2.1M | 325.0K | — | — |
| Q1 2026 | $2.4M | 325.0K | — | — |
Other funds holding EPRX
Other Aisling Capital Management LP positions
BBIO
$389.3MBridgeBio Pharma Inc. (BBIO)
BBIO
$378MBridgeBio Pharma Inc. (BBIO)
BBIO
$341.8MBRIDGEBIO PHARMA INC
BBIO
$203.3MBRIDGEBIO PHARMA INC
MNST
$37.6MMONTE ROSA THERAPEUTICS INC
SNDX
$30.8MSyndax Pharmaceuticals, Inc. (SNDX)
SNDX
$28.8MSYNDAX PHARMACEUTICALS INC
SNDX
$27.7MSyndax Pharmaceuticals, Inc. (SNDX)